纽约一线医生Dr. Daniel Griffin(PhD MD)新冠更新(August 7, 2021)
文章来源: 蓝调 于 2021-08-07 10:18:55
In COVID-19 clinical update #74, Daniel Griffin covers infections in vaccinated individuals, expansion of Regeneron monoclonal antibody cocktail for prophylaxis, neutralization of variants by antibodies produced by infection or vaccination, longer hospital stays associated with remdesivir treatment, and post-acute sequelae of infection and impact on quality of life 1-6 months after illness.